← All Pavmed INC filings

Pavmed INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
PAVM
Pavmed INC
SCHEDULE: PAVmed Inc. Insider Ownership Filing
Lishan Aklog, Chairman and CEO of PAVmed Inc., reports beneficial ownership of 5.1% of the company's common stock.
NASDAQ
PAVM
Pavmed INC
SCHEDULE: PAVmed Amends Lucid Diagnostics Stake, Adds Voting Control
PAVmed Inc. filed an Amendment No. 6 to its Schedule 13D, detailing an updated beneficial ownership of 27.5% in Lucid Diagnostics Inc. and new agreements impacting voting control.
NASDAQ
PAVM
Pavmed INC
SCHEDULE: PAVmed Boosts Lucid Diagnostics Stake to 28.3%
PAVmed Inc. has increased its beneficial ownership in Lucid Diagnostics Inc. to 28.3%, solidifying its influence through new stock awards and voting agreements.